About Pellets Pharma Limited
Data last updated:
Pellets Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PLC042853. Its GSTIN is 36AADCP2142G1ZQ (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹83.36 Lakh. It is led by directors including Pathuru Sreelatha (Managing Director) and Srinivasa Rao Jetti (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.784 Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹72.09 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹23.12 Cr (net margin 32.1%) and EBITDA of ₹34.17 Cr (EBITDA margin 47.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 7% over five years.
The company has about 177 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pellets Pharma. As per MCA filings, the company has satisfied charges of ₹25 Lakh on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 5 cases are pending. The company has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹38.5 Lakh; the latest was in September 2024. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Sreepathi Pharmaceuticals Limited with revenue of ₹74.26 Cr. The company has 8 MSME Form 1 returns on record between 2017 and 2020, listing 25 overdue payments to 13 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pelletspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.784 Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pellets Pharma Limited
The main business activity of Pellets Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pellets Pharma Limited FY 2024 filings available
Pellets Pharma Limited reported revenue of ₹72.09 Cr (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pellets Pharma Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 2% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pellets Pharma Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹34.17 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹23.12 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pellets Pharma Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 47.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 32.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pellets Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pellets Pharma Limited
Pellets Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sreepathi Pharmaceuticals Limited | ₹74.26 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Telangana, India |
| Apister Lifesciences Private Limited | ₹73.56 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Ahmedabad, Gujarat, India |
| Tyche Industries Limited Listed | ₹72.89 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Hyderabad, Telangana, India |
| Lavender Laboratories Private Limited | ₹72.29 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Pune, Maharashtra, India |
| S R Laboratories Private Limited | ₹72.1 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Telangana, India |
| Pellets Pharma Limited this company | ₹72.09 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Chemcrux Enterprises Limited Listed | ₹71.5 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Vadodara, Gujarat, India |
| Nico Orgo Marketing Private Limited | ₹70.53 Cr (FY 2024) | •••• | •••• | -50.0% | •••• | Kheda, Gujarat, India |
| Actis Generics Private Limited | ₹70.08 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Vijayawada, Andhra Pradesh, India |
| Amsal-Chem Private Limited | ₹69.92 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Ankleshwar, Gujarat, India |
| Vibrant Pharmachem Private Limited | ₹69.73 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Raichur, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Pellets Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pellets Pharma Limited
Pellets Pharma Limited is audited by RAO & SIVA ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAO & SIVA ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pellets Pharma Limited
Pellets Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Rao Jetti | Whole-Time Director | 30 Sep 2024 | 2 Years 0 Months | Current |
| Pathuru Sreelatha | Managing Director | 11 Mar 2004 | 22 Years 7 Months | Current |
| Pathuru Vamsi Krishna | Whole-Time Director | 18 Jul 2019 | 7 Years 2 Months | Current |
| Pathuru Aasritha | Director | 30 Sep 2024 | 2 Years 0 Months | Current |
Ownership and Shareholding of Pellets Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pellets Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2005 | The Dhanalakshmi Bank Ltd | ₹25 Lakh | Satisfied |
Total charge records: 1 View all charges
Deals & Funding of Pellets Pharma Limited
Pellets Pharma Limited has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹38.5 Lakh; the latest was in September 2024.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2024 | Secondary share transfer | Undisclosed | Seller: 3 individuals |
| Aug 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Apr 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Apr 2022 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
Full deal history
All 8 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Pellets Pharma Limited
Pellets Pharma Limited has 8 court cases on record: 4 filed by Pellets Pharma, 4 filed against it. 5 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 4 |
| District courts | 4 | 4 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Revision petition | Filed by the company against an individual | Pending |
| District court, Sangareddy, Telangana | Execution petition | Filed against the company by an individual | Pending |
| High Court for State of Telangana | Court case (AS) | Filed by the company against an individual | Pending |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Andhra Pradesh | Pending |
| District court, Sangareddy, Telangana | Execution petition | Filed against the company by an individual | Disposed |
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Pellets Pharma Limited
Pellets Pharma Limited has 8 MSME Form 1 returns on record between 2017 and 2020, listing 25 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 13)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dharma & Co | •••• | •••• | •••• |
| Lab Needs | •••• | •••• | •••• |
| Advanced Chromatography Technologies Private Limited | •••• | •••• | •••• |
| Ujwal Enviro Labs | •••• | •••• | •••• |
| Startech Labs Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 8 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Pellets Pharma Limited
Pellets Pharma operates one associated brand: Pellets Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in developing and manufacturing modified release pellets for various APIs. | pelletspharma.com |
Employees and EPFO Compliance at Pellets Pharma Limited
Pellets Pharma Limited has a workforce of 177 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Pellets Pharma Limited
Pellets Pharma has one previous CIN (Corporate Identification Number): U24239AP2004PLC042853. The current CIN is U24239TG2004PLC042853, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PLC042853 | Current |
| U24239AP2004PLC042853 | Previous |
Recent Activity on Pellets Pharma Limited
Pellets Pharma Limited has 9 board changes on record since 2004: 4 appointments and 5 cessations. The latest: Pathuru Aasritha was appointed as Director on 30 Sep 2024.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pellets Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pellets Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pellets Pharma Limited
Pellets Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCP2142G1ZQ | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pellets Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pellets Pharma Limited
Pellets Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 11 March 2004 (22+ years old) and is registered under CIN U24239TG2004PLC042853.
Pellets Pharma reported revenue of ₹72.09 Cr for FY 2024 (up 2% YoY).
Pellets Pharma has 4 current directors:
- Pathuru Sreelatha - Managing Director
- Srinivasa Rao Jetti - Whole-Time Director
- Pathuru Vamsi Krishna - Whole-Time Director
- Pathuru Aasritha - Director
Pellets Pharma reported a net profit of ₹23.12 Cr (net margin 32.1%) and EBITDA of ₹34.17 Cr (EBITDA margin 47.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pellets Pharma is 18% over three years and 7% over five years. In the latest year (FY 2024) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pellets Pharma is 36AADCP2142G1ZQ, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Pellets Pharma is U24239TG2004PLC042853. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pellets Pharma has 8 court cases on record: 4 filed by the company and 4 filed against it. 5 are pending. Most are in the high courts.
Pellets Pharma was incorporated on 11 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pellets Pharma has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹38.5 Lakh; the latest was in September 2024.
The peers of Pellets Pharma by revenue are Sreepathi Pharmaceuticals Limited, Apister Lifesciences Private Limited, Tyche Industries Limited, Lavender Laboratories Private Limited, S R Laboratories Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Pathuru Aasritha was appointed as Director on 30 Sep 2024. Srinivasa Rao Jetti was appointed as Whole-Time Director on 30 Sep 2024. Pathuru Vamsi Krishna was appointed as Whole-Time Director on 18 Jul 2019. Pellets Pharma has 9 board changes on record in total.